290 related articles for article (PubMed ID: 16300642)
1. 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease.
Brouillet E; Jacquard C; Bizat N; Blum D
J Neurochem; 2005 Dec; 95(6):1521-40. PubMed ID: 16300642
[TBL] [Abstract][Full Text] [Related]
2. Death of cortical and striatal neurons induced by mitochondrial defect involves differential molecular mechanisms.
Galas MC; Bizat N; Cuvelier L; Bantubungi K; Brouillet E; Schiffmann SN; Blum D
Neurobiol Dis; 2004 Feb; 15(1):152-9. PubMed ID: 14751780
[TBL] [Abstract][Full Text] [Related]
3. Astrocytes from cortex and striatum show differential responses to mitochondrial toxin and BDNF: implications for protection of striatal neurons expressing mutant huntingtin.
Saba J; López Couselo F; Turati J; Carniglia L; Durand D; de Laurentiis A; Lasaga M; Caruso C
J Neuroinflammation; 2020 Oct; 17(1):290. PubMed ID: 33023623
[TBL] [Abstract][Full Text] [Related]
4. Memantine reduces striatal cell death with decreasing calpain level in 3-nitropropionic model of Huntington's disease.
Lee ST; Chu K; Park JE; Kang L; Ko SY; Jung KH; Kim M
Brain Res; 2006 Nov; 1118(1):199-207. PubMed ID: 16959224
[TBL] [Abstract][Full Text] [Related]
5. Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies.
Ouary S; Bizat N; Altairac S; Ménétrat H; Mittoux V; Condé F; Hantraye P; Brouillet E
Neuroscience; 2000; 97(3):521-30. PubMed ID: 10828534
[TBL] [Abstract][Full Text] [Related]
6. Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's disease.
Ramaswamy S; McBride JL; Herzog CD; Brandon E; Gasmi M; Bartus RT; Kordower JH
Neurobiol Dis; 2007 May; 26(2):375-84. PubMed ID: 17336076
[TBL] [Abstract][Full Text] [Related]
7. Minocycline in phenotypic models of Huntington's disease.
Bantubungi K; Jacquard C; Greco A; Pintor A; Chtarto A; Tai K; Galas MC; Tenenbaum L; Déglon N; Popoli P; Minghetti L; Brouillet E; Brotchi J; Levivier M; Schiffmann SN; Blum D
Neurobiol Dis; 2005 Feb; 18(1):206-17. PubMed ID: 15649711
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective role for the p50 subunit of NF-kappaB in an experimental model of Huntington's disease.
Yu Z; Zhou D; Cheng G; Mattson MP
J Mol Neurosci; 2000 Aug; 15(1):31-44. PubMed ID: 11211235
[TBL] [Abstract][Full Text] [Related]
9. Calpain is a major cell death effector in selective striatal degeneration induced in vivo by 3-nitropropionate: implications for Huntington's disease.
Bizat N; Hermel JM; Boyer F; Jacquard C; Créminon C; Ouary S; Escartin C; Hantraye P; Kajewski S; Brouillet E
J Neurosci; 2003 Jun; 23(12):5020-30. PubMed ID: 12832525
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial toxin 3-nitropropionic acid produces startle reflex abnormalities and striatal damage in rats that model some features of Huntington's disease.
Kodsi MH; Swerdlow NR
Neurosci Lett; 1997 Aug; 231(2):103-7. PubMed ID: 9291151
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria in Huntington's disease.
Damiano M; Galvan L; Déglon N; Brouillet E
Biochim Biophys Acta; 2010 Jan; 1802(1):52-61. PubMed ID: 19682570
[TBL] [Abstract][Full Text] [Related]
12. Replicating Huntington's disease phenotype in experimental animals.
Brouillet E; Condé F; Beal MF; Hantraye P
Prog Neurobiol; 1999 Dec; 59(5):427-68. PubMed ID: 10515664
[TBL] [Abstract][Full Text] [Related]
13. Participation of par-4 in the degeneration of striatal neurons induced by metabolic compromise with 3-nitropropionic acid.
Duan W; Guo Z; Mattson MP
Exp Neurol; 2000 Sep; 165(1):1-11. PubMed ID: 10964480
[TBL] [Abstract][Full Text] [Related]
14. [Model of Huntington's disease induced with 3-nitropropionic acid].
Túnez I; Santamaría A
Rev Neurol; 2009 Apr 16-30; 48(8):430-4. PubMed ID: 19340784
[TBL] [Abstract][Full Text] [Related]
15. Increased calbindin-D28k immunoreactivity in striatal projection neurons of R6/2 Huntington's disease transgenic mice.
Sun Z; Wang HB; Deng YP; Lei WL; Xie JP; Meade CA; Del Mar N; Goldowitz D; Reiner A
Neurobiol Dis; 2005 Dec; 20(3):907-17. PubMed ID: 15990326
[TBL] [Abstract][Full Text] [Related]
16. Heat shock transcription factor-1 suppresses apoptotic cell death and ROS generation in 3-nitropropionic acid-stimulated striatal cells.
Choi YJ; Om JY; Kim NH; Chang JE; Park JH; Kim JY; Lee HJ; Kim SS; Chun W
Mol Cell Biochem; 2013 Mar; 375(1-2):59-67. PubMed ID: 23225230
[TBL] [Abstract][Full Text] [Related]
17. IGF-1 exacerbates the neurotoxicity of the mitochondrial inhibitor 3NP in rats.
Escartin C; Boyer F; Bemelmans AP; Hantraye P; Brouillet E
Neurosci Lett; 2007 Oct; 425(3):167-72. PubMed ID: 17868993
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of mitochondrial complex II alters striatal expression of genes involved in glutamatergic and dopaminergic signaling: possible implications for Huntington's disease.
Napolitano M; Centonze D; Gubellini P; Rossi S; Spiezia S; Bernardi G; Gulino A; Calabresi P
Neurobiol Dis; 2004 Mar; 15(2):407-14. PubMed ID: 15006711
[TBL] [Abstract][Full Text] [Related]
19. Unraveling a role for dopamine in Huntington's disease: the dual role of reactive oxygen species and D2 receptor stimulation.
Charvin D; Vanhoutte P; Pagès C; Borrelli E; Caboche J
Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12218-23. PubMed ID: 16103364
[TBL] [Abstract][Full Text] [Related]
20. Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons.
Picconi B; Passino E; Sgobio C; Bonsi P; Barone I; Ghiglieri V; Pisani A; Bernardi G; Ammassari-Teule M; Calabresi P
Neurobiol Dis; 2006 Apr; 22(1):143-52. PubMed ID: 16326108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
